GrayMatters Health (GMH) is a health technology company developing and marketing solutions for treating mental disorders, based on the world’s first digital brain biomarkers. The company recently won the 2023 USA Prix Galien Best Startup award. GMH is currently deploying its FDA-cleared Prism for PTSD™ at select clinics in the USA to help patients gain control of their PTSD symptoms.
